CBG ultimately liberates killer T cells, which can increase the effectiveness of PD-1 blockers and other anti-cancer drugs.

And out of the three proteins, endocannabinoid release requires either gamma and beta together or alpha-synuclein by itself.

Cannabinoid medicines might apply to several other diseases if THC can gently inhibit this newly discovered critical cancer function.